Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients | MicrobiomeTrials← Back to trialsNCT07317154
Autologous Dendritic Cell Vaccine For Recurrent Respiratory Papillomatosis (RRP) Patients
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2026-09Est. Completion: 2027-06
Enrollment target: 9 participants Locations- Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Other microbiome trials you might be interested in
Respiratory Recurrent Papillomatosis (RRP)Human Papillomavirus (HPV)Papillomavirus InfectionLaryngeal DiseasesTracheal DiseasesRespiratory Tract Neoplasm
Background:
Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths called papilloma…
Bethesda, United StatesEst. completion Jul 1, 2029
Respiratory Tract DiseasesNeoplasmsNeoplasms by Histologic Type
Neoplasms, Glandular and Epithelial
Neoplasms, Squamous Cell
Tumor Virus Infections
Infections
Virus Diseases
DNA Virus Infections
Pathologic Processes
Disease Attributes
Recurrence
Papilloma
Respiratory Tract Infections
Papillomavirus Infections
Background:
Recurrent respiratory papillomatosis (RRP) is a rare disease that causes wart-like growths in the airways. …
Bethesda, United StatesEst. completion Jul 31, 2027